iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Download App
image

Themis Medicare announced the approval of its antiviral drug VIRALEXreg by the Drug Controller General of India The drug helps in early relief of the clinical symptoms in mild to moderate Covid-19 patients

image

Arihant Institute announced that an Extra Ordinary General Meeting EGM of the Company will be held on 8 April 2022

image

Ratnamani Metals Tubes has received a new domestic line pipe order for Rs 591 crore from the oil and gas sector to be executed between August 2022 to March 2023

image

Crown Lifters will hold a meeting of the Board of Directors of the Company on 24 March 2022

image

SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool to manufacture nirmatrelive an oral anti-viral COVID-19 medicine developed by Pfizer to increase broad access of treatment in 95 low- and mid-income countries

image

Precision Containeurs has cancelled the board meeting which was scheduled to be held on 22 March 2022

image

Asian Granito India has filed draft papers Draft Letter of Offer for Rights Issue of equity shares to raise up to Rs 500 crore USD 70 Mn The Company has lined up Mega Expansion Plan in Value Added Luxury Surfaces Bathware Segments such as GVT Tiles Sanitaryware and SPC Flooring segments through setting up new state-of-the-art manufacturing facilities at Morbi Gujarat under newly incorporated wholly […]

image

Glenmark Pharmaceuticals Inc USA Glenmark has received final approval by the United States Food Drug Administration US FDA for its Lacosamide Tablets USP50 mg 100 mg 150 mg and 200 mg the generic version of Vimpat Tablets 50 mg 100 mg 150 mg and 200 mg of UCB Inc The company plans to launch the product immediately According to IQVIAtrade; sales data for the 12 […]

image

Alembic Pharmaceuticals announced that it has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Lacosamide Tablets USP 50 mg 100 mg 150 mg and 200 mg The approved ANDA is therapeutically equivalent to the reference listed drug product RLD Vimpat Tablets 50 mg 100 mg 150 mg and 200 mg of UCB Inc Lacosamide Tablets […]

image

Equitas Small Finance Bank announced the revision of interest rates for Savings and Retail Term Deposits from 21 March 2022 Customers can now avail 7Percentage interest pa on Savings Account for balances above Rs 5 lakh up to Rs 2 crore which was earlier above Rs 5 lakhs up to Rs 50 lakhs making it simpler for more customers to earn more interest through saving […]

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.